188 related articles for article (PubMed ID: 30145321)
1. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
Podkowa K; Pilc A; Podkowa A; Sałat K; Marciniak M; Pałucha-Poniewiera A
Neuropharmacology; 2018 Oct; 141():214-222. PubMed ID: 30145321
[TBL] [Abstract][Full Text] [Related]
2. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.
Palucha A; Klak K; Branski P; van der Putten H; Flor PJ; Pilc A
Psychopharmacology (Berl); 2007 Nov; 194(4):555-62. PubMed ID: 17622518
[TBL] [Abstract][Full Text] [Related]
3. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
Pałucha-Poniewiera A; Szewczyk B; Pilc A
Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
[TBL] [Abstract][Full Text] [Related]
4. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-like effects of scopolamine in mice are enhanced by the group II mGlu receptor antagonist LY341495.
Podkowa K; Podkowa A; Sałat K; Lenda T; Pilc A; Pałucha-Poniewiera A
Neuropharmacology; 2016 Dec; 111():169-179. PubMed ID: 27569995
[TBL] [Abstract][Full Text] [Related]
6. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
[TBL] [Abstract][Full Text] [Related]
7. A selective mGlu7 receptor antagonist MMPIP reversed antidepressant-like effects of AMN082 in rats.
Pałucha-Poniewiera A; Pilc A
Behav Brain Res; 2013 Feb; 238():109-12. PubMed ID: 23085340
[TBL] [Abstract][Full Text] [Related]
8. The effects of mGlu₇ receptor modulation in behavioural models sensitive to antidepressant action in two mouse strains.
O'Connor RM; Cryan JF
Behav Pharmacol; 2013 Apr; 24(2):105-13. PubMed ID: 23455446
[TBL] [Abstract][Full Text] [Related]
9. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.
Bradley SR; Uslaner JM; Flick RB; Lee A; Groover KM; Hutson PH
Pharmacol Biochem Behav; 2012 Mar; 101(1):35-40. PubMed ID: 22138407
[TBL] [Abstract][Full Text] [Related]
10. Impact of the metabotropic glutamate receptor7 (mGlu
Kotlinska JH; Lopatynska-Mazurek M; Gawel K; Gabka P; Jenda-Wojtanowska M; Kruk-Slomka M; Marszalek-Grabska M; Danilczuk Z; Kedzierska E; Talarek S; Listos J; Gibula-Tarlowska E
Eur J Pharmacol; 2019 Sep; 858():172512. PubMed ID: 31260653
[TBL] [Abstract][Full Text] [Related]
11. The effects of metabotropic glutamate receptor 7 allosteric agonist N,N'-dibenzhydrylethane-1,2-diamine dihydrochloride on developmental sevoflurane neurotoxicity: role of extracellular signal-regulated kinase 1 and 2 mitogen-activated protein kinase signaling pathway.
Wang WY; Wang H; Luo Y; Jia LJ; Zhao JN; Zhang HH; Ma ZW; Xue QS; Yu BW
Neuroscience; 2012 Mar; 205():167-77. PubMed ID: 22244976
[TBL] [Abstract][Full Text] [Related]
12. AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice.
Jenda M; Gawel K; Marszalek M; Komsta L; Kotlinska JH
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():166-75. PubMed ID: 25448778
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death.
Domin H; Jantas D; Śmiałowska M
Neurochem Int; 2015 Sep; 88():110-23. PubMed ID: 25576184
[TBL] [Abstract][Full Text] [Related]
14. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
Wierońska JM; Stachowicz K; Acher F; Lech T; Pilc A
Psychopharmacology (Berl); 2012 Apr; 220(3):481-94. PubMed ID: 21952670
[TBL] [Abstract][Full Text] [Related]
15. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
Greco B; Lopez S; van der Putten H; Flor PJ; Amalric M
J Pharmacol Exp Ther; 2010 Mar; 332(3):1064-71. PubMed ID: 19940105
[TBL] [Abstract][Full Text] [Related]
16. Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice.
Singh P; Singh TG
Indian J Pharmacol; 2015; 47(4):388-93. PubMed ID: 26288470
[TBL] [Abstract][Full Text] [Related]
17. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.
Podkowa K; Rzeźniczek S; Marciniak M; Acher F; Pilc A; Pałucha-Poniewiera A
Neuropharmacology; 2015 Oct; 97():338-45. PubMed ID: 26074092
[TBL] [Abstract][Full Text] [Related]
18. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
Summa M; Di Prisco S; Grilli M; Usai C; Marchi M; Pittaluga A
Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
[TBL] [Abstract][Full Text] [Related]
19. Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal.
Wang CC; Kuo JR; Huang SK; Wang SJ
Eur J Pharmacol; 2018 Mar; 823():11-18. PubMed ID: 29378190
[TBL] [Abstract][Full Text] [Related]
20. Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.
Hughes ZA; Neal SJ; Smith DL; Sukoff Rizzo SJ; Pulicicchio CM; Lotarski S; Lu S; Dwyer JM; Brennan J; Olsen M; Bender CN; Kouranova E; Andree TH; Harrison JE; Whiteside GT; Springer D; O'Neil SV; Leonard SK; Schechter LE; Dunlop J; Rosenzweig-Lipson S; Ring RH
Neuropharmacology; 2013 Mar; 66():202-14. PubMed ID: 22551786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
